W. Conrad Liles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
W. Conrad Liles has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
David C. Dale
From the Department of Medicine, University of Washington, and The Puget Sound Blood Center, Seattle, Washington
5 shared publicationsJ. Milton Gaviria
From the Department of Medicine, University of Washington, and The Puget Sound Blood Center, Seattle, Washington
3 shared publications- Jo-Anne H. Young
Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
2 shared publications Kai Hübel
Department of Medicine, University of Washington, Seattle, Washington, USA and Department I of Internal Medicine, University of Cologne, Cologne, Germany
2 shared publicationsRichard K. Root
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Harborview Medical Center, and Fred Hutchinson Cancer Research Center, Seattle, Washington
2 shared publicationsAndreas Engert
Department I of Internal Medicine, University of Cologne, Cologne, Germany
1 shared publication
Latest Publications
- 10 October 2005
- Published by Wiley in Transfusion
- Vol. 45 (12) , 1876-1889
Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte–colony‐stimulating factor
BACKGROUND: Donor stimulation with granulocyte–colony‐stimulating factor (G‐CSF) has increased the number of neutrophils (PMNs) that can be collected for granulocyte transfusion therapy. Clinical utility, however, has been limited by the inability to store functional PMNs ex vivo. This study was conducted to determine whether granulocyte products from G‐CSF–stimulated donors could be effectively stored at reduced temperature (22°C vs. 10°C) with maintenance of functional properties in vitro and in vivo.STUDY DESIGN AND METHODS: Nine normal subjects received G‐CSF (600 µg subcutaneously) 12 hours before centrifugation leukapheresis. Granulocyte products were divided and stored for 24 and 48 hours under four conditions: 1) 22°C; 2) 22°C, with supplemental G‐CSF (100 ng/mL); 3) 10°C; and 4) 10°C, with supplemental G‐CSF. Functional PMN activity during ex vivo storage was assessed in vitro and in vivo by the skin‐window technique for granulocytes stored at 10°C for 24 hours.RESULTS: Surface expression of CD11b/CD18, CD14, CD16, CD32, and CD64 was maintained during 48‐hour storage at reduced temperature. Inducible respiratory burst activity, bactericidal activity, and fungicidal activity were preserved during storage for 48‐hour storage at 10°C. Proinflammatory cytokine production was decreased in product stored at 10°C. Supplemental G‐CSF ex vivo did not substantially improve functional activity during storage. After storage at 10°C for 24 hours, in vitro chemotactic potential was maintained, and transfused granulocytes retained capacity to circulate and migrate appropriately in vivo.CONCLUSIONS: Granulocyte product collected by centrifugation leukapheresis from G‐CSF–stimulated donors can be effectively stored at subphysiologic temperature for 24 hours with preservation of functional activity. Storage at 10°C appears to be slightly superior to storage at 22°C.
- 10 October 2005
- Published by Wiley in Transfusion
- Vol. 45 (12) , 1876-1889
Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte–colony‐stimulating factor
BACKGROUND: Donor stimulation with granulocyte–colony‐stimulating factor (G‐CSF) has increased the number of neutrophils (PMNs) that can be collected for granulocyte transfusion therapy. Clinical utility, however, has been limited by the inability to store functional PMNs ex vivo. This study was conducted to determine whether granulocyte products from G‐CSF–stimulated donors could be effectively stored at reduced temperature (22°C vs. 10°C) with maintenance of functional properties in vitro and in vivo.STUDY DESIGN AND METHODS: Nine normal subjects received G‐CSF (600 µg subcutaneously) 12 hours before centrifugation leukapheresis. Granulocyte products were divided and stored for 24 and 48 hours under four conditions: 1) 22°C; 2) 22°C, with supplemental G‐CSF (100 ng/mL); 3) 10°C; and 4) 10°C, with supplemental G‐CSF. Functional PMN activity during ex vivo storage was assessed in vitro and in vivo by the skin‐window technique for granulocytes stored at 10°C for 24 hours.RESULTS: Surface expression of CD11b/CD18, CD14, CD16, CD32, and CD64 was maintained during 48‐hour storage at reduced temperature. Inducible respiratory burst activity, bactericidal activity, and fungicidal activity were preserved during storage for 48‐hour storage at 10°C. Proinflammatory cytokine production was decreased in product stored at 10°C. Supplemental G‐CSF ex vivo did not substantially improve functional activity during storage. After storage at 10°C for 24 hours, in vitro chemotactic potential was maintained, and transfused granulocytes retained capacity to circulate and migrate appropriately in vivo.CONCLUSIONS: Granulocyte product collected by centrifugation leukapheresis from G‐CSF–stimulated donors can be effectively stored at subphysiologic temperature for 24 hours with preservation of functional activity. Storage at 10°C appears to be slightly superior to storage at 22°C.
- Open Access
- 15 May 2002
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 185 (10) , 1490-1501
Therapeutic Use of Cytokines to Modulate Phagocyte Function for the Treatment of Infectious Diseases: Current Status of Granulocyte Colony‐Stimulating Factor, Granulocyte‐Macrophage Colony‐Stimulating Factor, Macrophage Colony‐Stimulating Factor, and Interferon‐γ
The innate immune system represents the initial arm of host defense against pathogenic bacteria, fungi, and parasites. Neutrophils, monocytes, and ti
- 15 May 2002
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 185 (10) , 1490-1501
Open AccessTherapeutic Use of Cytokines to Modulate Phagocyte Function for the Treatment of Infectious Diseases: Current Status of Granulocyte Colony‐Stimulating Factor, Granulocyte‐Macrophage Colony‐Stimulating Factor, Macrophage Colony‐Stimulating Factor, and Interferon‐γ
The innate immune system represents the initial arm of host defense against pathogenic bacteria, fungi, and parasites. Neutrophils, monocytes, and ti
- 1 July 2001
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 70 (1) , 96-102
Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin
Modulins represent microbial products that stimulate cytokine production in host cells. The modulins responsible for gram-positive sepsis remain poorly understood. Staphylococci release a factor (or factors) that activates nuclear factor-κB and stimulates cytokine production in cells of macrophage lineage. This factor, termed phenol-soluble modulin (PSM), has been recently isolated from culture supernatant of Staphylococcus epidermidis. We examined the effects of PSM on proinflammatory properties of human neutrophils and monocytes in vitro. PSM activated the respiratory (oxidative) burst in neutrophils and primed neutrophils for enhanced respiratory burst activity in response to formyl-methionyl-leucyl-phenylalanine. PSM also stimulated neutrophil degranulation as reflected by increased surface expression of CD11b and CD18, which was accompanied by rapid shedding of l-selectin. Spontaneous apoptosis of both neutrophils and monocytes was inhibited by PSM. Furthermore, PSM also functioned as a chemoattractant factor for both neutrophils and monocytes. Thus, the proinflammatory properties of PSM resemble those of both lipopolysaccharide and bacterial chemotactic peptides. These findings suggest that PSM may play a role in the pathogenesis and systemic manifestations of sepsis caused by staphylococci.
- 1 July 2001
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 70 (1) , 96-102
Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin
Modulins represent microbial products that stimulate cytokine production in host cells. The modulins responsible for gram-positive sepsis remain poorly understood. Staphylococci release a factor (or factors) that activates nuclear factor-κB and stimulates cytokine production in cells of macrophage lineage. This factor, termed phenol-soluble modulin (PSM), has been recently isolated from culture supernatant of Staphylococcus epidermidis. We examined the effects of PSM on proinflammatory properties of human neutrophils and monocytes in vitro. PSM activated the respiratory (oxidative) burst in neutrophils and primed neutrophils for enhanced respiratory burst activity in response to formyl-methionyl-leucyl-phenylalanine. PSM also stimulated neutrophil degranulation as reflected by increased surface expression of CD11b and CD18, which was accompanied by rapid shedding of l-selectin. Spontaneous apoptosis of both neutrophils and monocytes was inhibited by PSM. Furthermore, PSM also functioned as a chemoattractant factor for both neutrophils and monocytes. Thus, the proinflammatory properties of PSM resemble those of both lipopolysaccharide and bacterial chemotactic peptides. These findings suggest that PSM may play a role in the pathogenesis and systemic manifestations of sepsis caused by staphylococci.
- 1 March 2001
- Published by Elsevier in Seminars in Respiratory Infections
- Vol. 16 (1) , 11-17
Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases
- 1 March 2001
- Published by Elsevier in Seminars in Respiratory Infections
- Vol. 16 (1) , 11-17
Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases
- Open Access
- 15 January 2001
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 183 (2) , 321-328
Current Status of Granulocyte (Neutrophil) Transfusion Therapy for Infectious Diseases
The transfusion of neutrophils, or granulocyte transfusion therapy, has long been considered as a logical approach to the treatment of severe bacteri
- 15 January 2001
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 183 (2) , 321-328
Open AccessCurrent Status of Granulocyte (Neutrophil) Transfusion Therapy for Infectious Diseases
The transfusion of neutrophils, or granulocyte transfusion therapy, has long been considered as a logical approach to the treatment of severe bacteri
- Open Access
- 1 May 1999
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 179 (5) , 1301-1304
Modulation of Neutrophil‐Mediated Activity Against the Pseudohyphal Form ofCandida albicansby Granulocyte Colony‐Stimulating Factor (G‐CSF) Administered In Vivo
Renewed interest in neutrophil transfusions has emerged with the development and clinical use of granulocyte colony-stimulating factor (G-CSF). G-CSF
- 1 May 1999
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 179 (5) , 1301-1304
Open AccessModulation of Neutrophil‐Mediated Activity Against the Pseudohyphal Form ofCandida albicansby Granulocyte Colony‐Stimulating Factor (G‐CSF) Administered In Vivo
Renewed interest in neutrophil transfusions has emerged with the development and clinical use of granulocyte colony-stimulating factor (G-CSF). G-CSF
- 1 April 1999
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 179 (4) , 1038-1041
Comparison of Interferon‐γ, Granulocyte Colony‐Stimulating Factor, and Granulocyte‐Macrophage Colony‐Stimulating Factor for Priming Leukocyte‐Mediated Hyphal Damage of Opportunistic Fungal Pathogens
Proinflammatory cytokines have been proposed as adjunctive therapeutic agents to enhance the host immune response during infections caused by opportunistic fungi. The study compared the differential in vitro priming effects of interferon-γ (IFN-γ), granulocyte colony-stimulating factor (G-CSF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) on hyphal damage of opportunistic fungi mediated by isolated neutrophils (polymorphonuclear leukocytes, PMNL) and buffy coat cells (polymorphonuclear leukocytes/peripheral blood mononuclear cells, PMNL/PBMC) from healthy donors. IFN-γ (1000 U/mL) effectively primed both PMNL and PMNL/PBMC for enhanced hyphal damage of Aspergillus fumigatus, Fusarium solani, and Candida albicans. G-CSF (100 ng/mL) increased hyphal damage mediated by both PMNL and PMNL/PBMC against F. solani, and GM-CSF (100 ng/mL) augmented the antifungal activity of PMNL/PBMC against hyphal forms of both F. solani and C. albicans. IFN-γ may be superior to G-CSF or GM-CSF for enhancing the microbicidal activity of PMNL and PMNL/PBMC against opportunistic fungi.
- 1 April 1999
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 179 (4) , 1038-1041
Comparison of Interferon‐γ, Granulocyte Colony‐Stimulating Factor, and Granulocyte‐Macrophage Colony‐Stimulating Factor for Priming Leukocyte‐Mediated Hyphal Damage of Opportunistic Fungal Pathogens
Proinflammatory cytokines have been proposed as adjunctive therapeutic agents to enhance the host immune response during infections caused by opportunistic fungi. The study compared the differential in vitro priming effects of interferon-γ (IFN-γ), granulocyte colony-stimulating factor (G-CSF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) on hyphal damage of opportunistic fungi mediated by isolated neutrophils (polymorphonuclear leukocytes, PMNL) and buffy coat cells (polymorphonuclear leukocytes/peripheral blood mononuclear cells, PMNL/PBMC) from healthy donors. IFN-γ (1000 U/mL) effectively primed both PMNL and PMNL/PBMC for enhanced hyphal damage of Aspergillus fumigatus, Fusarium solani, and Candida albicans. G-CSF (100 ng/mL) increased hyphal damage mediated by both PMNL and PMNL/PBMC against F. solani, and GM-CSF (100 ng/mL) augmented the antifungal activity of PMNL/PBMC against hyphal forms of both F. solani and C. albicans. IFN-γ may be superior to G-CSF or GM-CSF for enhancing the microbicidal activity of PMNL and PMNL/PBMC against opportunistic fungi.